Dr. Lam explains why when many cancers are decreasing in incidence, kidney cancer is seeing an increase.
Colon cancer being the third leading cause of cancer deaths in the United States, healthcare providers saw a 90% decrease in colon cancer screenings in 2020. Dr. Sunnie Kim joined the Kathie J Show to stress the importance of regular screenings, while spreading awareness, and providing health tips.
The Division of Medical Oncology is excited to welcome Sami Diab, MD, as Associate Professor of Medicine and Medical Director of Oncology at the Lone Tree Medical Center.
Tejas Patil, MD, has been named recipient of the 2022 Hamoui Foundation and LUNGevity Clinical Research Award for his research surrounding RET-positive lung cancer.
With more than 30 years of clinical experience, Marie Wood, MD, has joined the Division of Medical Oncology as a clinical professor with the breast team.
Dr. Kessler discusses how oncologists at the University of Colorado Anschutz Medical Campus have applied clinical research to the treatment of prostate cancers.
Poster presentation by Dr. Elena Shagisultanova at the 2021 San Antonio Breast Cancer shows data from an exploratory analysis of intracranial efficacy in patients who had CNS metastases.
We are excited to announce the 2021 Hematology/Oncology Fellowship NRMP match results. This outstanding group of folks will be joining us in July 2022 as first year fellows.
Congratulations to Dr. Traci Lyons, recipient of the 2021 Mission Boost Grant from the American Cancer Society. The objective of Dr. Lyons research proposes the hypothesis that SEMA7A is an identifiable risk factor for breast cancer progression that would be monitored in high risk women.
Dr. Alexis Leal provides insight on fibrolamellar hepatocellular carcinoma (HCC) and identifies common symptoms associated with this very rare liver cancer that tends to strike children and young adults.
William Robinson, MD, PhD, discusses the scientific theory behind why melanomas that metastasize to the adrenal gland don’t respond to checkpoint inhibitor and provides his recommendation for patients moving forward.
Erin Schenk, MD, PhD, has been awarded the 10th annual LUNGevity Career Development Award which supports exceptional young researchers to augment the lung cancer research pipeline and advance the field.